Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Public Health | Research

Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework

Authors: Jan W. van der Scheer, Akbar Ansari, Meredith McLaughlin, Caitríona Cox, Kathleen Liddell, Jenni Burt, Jenny George, Rebecca Kenny, Ruth Cousens, Brandi Leach, James McGowan, Katherine Morley, Janet Willars, Mary Dixon-Woods

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

Workplace programmes to test staff for asymptomatic COVID-19 infection have become common, but raise a number of ethical challenges. In this article, we report the findings of a consultation that informed the development of an ethical framework for organisational decision-making about such programmes.

Methods

We conducted a mixed-method consultation – a survey and semi-structured interviews during November–December 2020 in a UK case study organisation that had introduced asymptomatic testing for all staff working on-site in its buildings. Analysis of closed-ended survey data was conducted descriptively. An analysis approach based on the Framework Method was used for the open-ended survey responses and interview data. The analyses were then integrated to facilitate systematic analysis across themes. Inferences were based on the integrated findings and combined with other inputs (literature review, ethical analysis, legal and public health guidance, expert discussions) to develop an ethical framework.

Results

The consultation involved 61 staff members from the case study organisation (50 survey respondents and 11 interview participants). There was strong support for the asymptomatic testing programme: 90% of the survey respondents viewed it as helpful or very helpful. Open-ended survey responses and interviews gave insight into participants’ concerns, including those relating to goal drift, risk of false negatives, and potential negative impacts for household members and people whose roles lacked contractual and financial stability. Integration of the consultation findings and the other inputs identified the importance of a whole-system approach with appropriate support for the key control measure of isolation following positive tests. The need to build trust in the testing programme, for example through effective communication from leaders, was also emphasised.

Conclusions

The consultation, together with other inputs, informed an ethical framework intended to support employers. The framework may support organisational decision-making in areas ranging from design and operation of the programme through to choices about participation. The framework is likely to benefit from further consultation and refinement in new settings.
Appendix
Available only for authorised users
Literature
6.
go back to reference Raffle AE, Pollock AM, Harding-Edgar L. Covid-19 mass testing programmes. BMJ. 2020;370:m3262. Raffle AE, Pollock AM, Harding-Edgar L. Covid-19 mass testing programmes. BMJ. 2020;370:m3262.
8.
go back to reference Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci MA, et al. Asymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. medRxiv. 2020:2020.04.25.20079103. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci MA, et al. Asymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. medRxiv. 2020:2020.04.25.20079103.
9.
go back to reference World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 16 March 2020. 2020. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 16 March 2020. 2020.
10.
go back to reference Johnson-León M, Caplan AL, Kenny L, Buchan I, Fesi L, Olhava P, et al. Executive summary: It’s wrong not to test: The case for universal, frequent rapid COVID-19 testing. EClinicalMedicine. 2021;33:100759.PubMedCentralCrossRefPubMed Johnson-León M, Caplan AL, Kenny L, Buchan I, Fesi L, Olhava P, et al. Executive summary: It’s wrong not to test: The case for universal, frequent rapid COVID-19 testing. EClinicalMedicine. 2021;33:100759.PubMedCentralCrossRefPubMed
11.
go back to reference Rosella LC, Agrawal A, Gans J, Goldfarb A, Sennik S, Stein J. Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces. Sci Adv. 2022;8(8):eabm3608.PubMedCentralCrossRefPubMed Rosella LC, Agrawal A, Gans J, Goldfarb A, Sennik S, Stein J. Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces. Sci Adv. 2022;8(8):eabm3608.PubMedCentralCrossRefPubMed
12.
go back to reference Zhou Y, Jiang H, Wang Q, Yang M, Chen Y, Jiang Q. Use of contact tracing, isolation, and mass testing to control transmission of covid-19 in China. BMJ. 2021;375:n2330.PubMedCentralCrossRefPubMed Zhou Y, Jiang H, Wang Q, Yang M, Chen Y, Jiang Q. Use of contact tracing, isolation, and mass testing to control transmission of covid-19 in China. BMJ. 2021;375:n2330.PubMedCentralCrossRefPubMed
13.
go back to reference Raffle AE. Screening the healthy population for covid-19 is of unknown value, but is being introduced nationwide. BMJ Opinion. 2020;371:m4438. Raffle AE. Screening the healthy population for covid-19 is of unknown value, but is being introduced nationwide. BMJ Opinion. 2020;371:m4438.
14.
go back to reference Mahase E. Covid-19: People are not being warned about pitfalls of mass testing. BMJ. 2021;372:n238.CrossRefPubMed Mahase E. Covid-19: People are not being warned about pitfalls of mass testing. BMJ. 2021;372:n238.CrossRefPubMed
15.
go back to reference Cox C, Dixon-Woods M. Need for ethical framework to guide mass testing for asymptomatic covid-19. BMJ. 2020;371:m4567.CrossRefPubMed Cox C, Dixon-Woods M. Need for ethical framework to guide mass testing for asymptomatic covid-19. BMJ. 2020;371:m4567.CrossRefPubMed
16.
go back to reference Kalokairinou L, Zettler PJ, Nagappan A, Kyweluk MA, Wexler A. The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues. J Law Biosci. 2020;7(1):lsaa069.PubMedCentralCrossRefPubMed Kalokairinou L, Zettler PJ, Nagappan A, Kyweluk MA, Wexler A. The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues. J Law Biosci. 2020;7(1):lsaa069.PubMedCentralCrossRefPubMed
17.
go back to reference SAGE Multidisciplinary Task and Finish Group on Mass Testing (TFMS). Consensus Statement for the Scientific Advisory Group for Emergencies (SAGE). 2020. SAGE Multidisciplinary Task and Finish Group on Mass Testing (TFMS). Consensus Statement for the Scientific Advisory Group for Emergencies (SAGE). 2020.
18.
go back to reference Studdert DM, Hall MA. Disease Control, civil liberties, and mass testing — calibrating restrictions during the Covid-19 pandemic. N Engl J Med. 2020;383(2):102–4.CrossRefPubMed Studdert DM, Hall MA. Disease Control, civil liberties, and mass testing — calibrating restrictions during the Covid-19 pandemic. N Engl J Med. 2020;383(2):102–4.CrossRefPubMed
19.
go back to reference Wise J. Covid-19: Government uses lateral flow tests to keep children in schools against regulator’s advice. BMJ. 2021;372:n148.CrossRefPubMed Wise J. Covid-19: Government uses lateral flow tests to keep children in schools against regulator’s advice. BMJ. 2021;372:n148.CrossRefPubMed
21.
go back to reference Iacobucci G. Covid-19: Mass testing at UK universities is haphazard and unscientific, finds BMJ investigation. BMJ. 2021;372:n848.CrossRefPubMed Iacobucci G. Covid-19: Mass testing at UK universities is haphazard and unscientific, finds BMJ investigation. BMJ. 2021;372:n848.CrossRefPubMed
22.
go back to reference Dennis A, Robin C, Carter H. The social media response to twice-weekly mass asymptomatic testing in England. BMC Public Health. 2022;22(1):1–12.CrossRef Dennis A, Robin C, Carter H. The social media response to twice-weekly mass asymptomatic testing in England. BMC Public Health. 2022;22(1):1–12.CrossRef
23.
go back to reference Cox C, Ansari A, McLaughlin M, Van Der Scheer J, Liddell K, Burt J, et al. Developing an ethical framework for asymptomatic COVID-19 testing programmes in higher education institutions. Wellcome Open Research. 2021;6:101.CrossRef Cox C, Ansari A, McLaughlin M, Van Der Scheer J, Liddell K, Burt J, et al. Developing an ethical framework for asymptomatic COVID-19 testing programmes in higher education institutions. Wellcome Open Research. 2021;6:101.CrossRef
24.
go back to reference Iacobucci G. Covid-19: Government rolls out twice weekly rapid testing to all in England. BMJ. 2021;373:n902.CrossRefPubMed Iacobucci G. Covid-19: Government rolls out twice weekly rapid testing to all in England. BMJ. 2021;373:n902.CrossRefPubMed
25.
go back to reference Barry G, McCarney C, Farrelly M, Breathnach R, Mooney C, More SJ. Rapid antigen testing for SARS-CoV-2 infection in a university setting in Ireland: learning from a 6-week pilot study. Public Health Pract. 2022;3:100255. Barry G, McCarney C, Farrelly M, Breathnach R, Mooney C, More SJ. Rapid antigen testing for SARS-CoV-2 infection in a university setting in Ireland: learning from a 6-week pilot study. Public Health Pract. 2022;3:100255.
26.
go back to reference French CE, Denford S, Brooks-Pollock E, Wehling H, Hickman M. Low uptake of COVID-19 lateral flow testing among university students: a mixed methods evaluation. Public Health Pract. 2022;204:54–62. French CE, Denford S, Brooks-Pollock E, Wehling H, Hickman M. Low uptake of COVID-19 lateral flow testing among university students: a mixed methods evaluation. Public Health Pract. 2022;204:54–62.
27.
go back to reference Li Z, Liu F, Cui J, Peng Z, Chang Z, Lai S, et al. Comprehensive large-scale nucleic acid–testing strategies support China’s sustained containment of COVID-19. Nat Med. 2021;27(5):740–2.CrossRefPubMed Li Z, Liu F, Cui J, Peng Z, Chang Z, Lai S, et al. Comprehensive large-scale nucleic acid–testing strategies support China’s sustained containment of COVID-19. Nat Med. 2021;27(5):740–2.CrossRefPubMed
28.
go back to reference Logan M, Hirst J, Fanshawe T, Mwandigha L, Wanat M, Vicary C, Hobbs R. Feasibility and Acceptability of community COVID-19 Testing Strategies (FACTS) in a University setting. Open Forum Infect Dis. 2021;8(12):ofab495 Logan M, Hirst J, Fanshawe T, Mwandigha L, Wanat M, Vicary C, Hobbs R. Feasibility and Acceptability of community COVID-19 Testing Strategies (FACTS) in a University setting. Open Forum Infect Dis. 2021;8(12):ofab495
32.
go back to reference Thornton M. Pandemics at work: convergence of epidemiology and ethics. Bus Ethics Q. 2022;32(1):41–74. Thornton M. Pandemics at work: convergence of epidemiology and ethics. Bus Ethics Q. 2022;32(1):41–74.
33.
go back to reference Kuhn E, Müller S, Heidbrink L, Buyx A. The ethics of workplace health promotion. Public Health Ethics. 2020;13(3):234–46.CrossRef Kuhn E, Müller S, Heidbrink L, Buyx A. The ethics of workplace health promotion. Public Health Ethics. 2020;13(3):234–46.CrossRef
34.
go back to reference Robroek SJW, van de Vathorst S, Hilhorst MT, Burdorf A. Moral issues in workplace health promotion. Int Arch Occup Environ Health. 2012;85(3):327–31.CrossRefPubMed Robroek SJW, van de Vathorst S, Hilhorst MT, Burdorf A. Moral issues in workplace health promotion. Int Arch Occup Environ Health. 2012;85(3):327–31.CrossRefPubMed
36.
go back to reference Van Berkel J, Meershoek A, Janssens RM, Boot CR, Proper KI, Van Der Beek AJ. Ethical considerations of worksite health promotion: an exploration of stakeholders’ views. BMC Public Health. 2014;14(1):458.PubMedCentralCrossRefPubMed Van Berkel J, Meershoek A, Janssens RM, Boot CR, Proper KI, Van Der Beek AJ. Ethical considerations of worksite health promotion: an exploration of stakeholders’ views. BMC Public Health. 2014;14(1):458.PubMedCentralCrossRefPubMed
37.
go back to reference Cashman CM, Ruotsalainen JH, Greiner BA, Beirne PV, Verbeek JH. Alcohol and drug screening of occupational drivers for preventing injury. Cochrane Database Syst Rev. 2009;2:CD006566. Cashman CM, Ruotsalainen JH, Greiner BA, Beirne PV, Verbeek JH. Alcohol and drug screening of occupational drivers for preventing injury. Cochrane Database Syst Rev. 2009;2:CD006566.
38.
go back to reference Gibson TM, Loza-Herrero MA, Yepes JF, Kim-Berman H, Dilbone DA, Perez H. Mandatory drug testing of dental students: to test or not to test. J Dent Educ. 2019;83(8):924.CrossRefPubMed Gibson TM, Loza-Herrero MA, Yepes JF, Kim-Berman H, Dilbone DA, Perez H. Mandatory drug testing of dental students: to test or not to test. J Dent Educ. 2019;83(8):924.CrossRefPubMed
39.
go back to reference Christie T. A discussion of the ethical implications of random drug testing in the workplace. Healthc Manage Forum. 2015;28(4):172–4.CrossRefPubMed Christie T. A discussion of the ethical implications of random drug testing in the workplace. Healthc Manage Forum. 2015;28(4):172–4.CrossRefPubMed
40.
go back to reference Schmid P, Rauber D, Betsch C, Lidolt G, Denker M-L. Barriers of influenza vaccination intention and behavior - a systematic review of influenza vaccine hesitancy, 2005–2016. PLoS ONE. 2017;12(1):e0170550.PubMedCentralCrossRefPubMed Schmid P, Rauber D, Betsch C, Lidolt G, Denker M-L. Barriers of influenza vaccination intention and behavior - a systematic review of influenza vaccine hesitancy, 2005–2016. PLoS ONE. 2017;12(1):e0170550.PubMedCentralCrossRefPubMed
41.
go back to reference Ishizaki A, Bouscaillou J, Luhmann N, Liu S, Chua R, Walsh N, et al. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries. BMC Infect Dis. 2017;17(S1):696.PubMedCentralCrossRefPubMed Ishizaki A, Bouscaillou J, Luhmann N, Liu S, Chua R, Walsh N, et al. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries. BMC Infect Dis. 2017;17(S1):696.PubMedCentralCrossRefPubMed
43.
go back to reference Fritz Z, Huxtable R, Ives J, Paton A, Slowther AM, Wilkinson D. Ethical road map through the covid-19 pandemic. BMJ. 2020;369:m2033. Fritz Z, Huxtable R, Ives J, Paton A, Slowther AM, Wilkinson D. Ethical road map through the covid-19 pandemic. BMJ. 2020;369:m2033.
45.
go back to reference SAGE Multidisciplinary Task and Finish Group on Mass Testing. Behavioural considerations. 2020. SAGE Multidisciplinary Task and Finish Group on Mass Testing. Behavioural considerations. 2020.
48.
go back to reference European Commission. In vitro diagnostic medical devices. Annex 1 of the EU Directive 98/79/EC. 2020. European Commission. In vitro diagnostic medical devices. Annex 1 of the EU Directive 98/79/EC. 2020.
49.
53.
54.
go back to reference Childress JF, Faden RR, Gaare RD, Gostin LO, Kahn J, Bonnie RJ, et al. Public health ethics: mapping the terrain. J Law Med Ethics. 2002;30(2):170–8.CrossRefPubMed Childress JF, Faden RR, Gaare RD, Gostin LO, Kahn J, Bonnie RJ, et al. Public health ethics: mapping the terrain. J Law Med Ethics. 2002;30(2):170–8.CrossRefPubMed
55.
56.
go back to reference Thompson AK, Faith K, Gibson JL, Upshur RE. Pandemic influenza preparedness: an ethical framework to guide decision-making. BMC Med Ethics. 2006;7:E12.CrossRefPubMed Thompson AK, Faith K, Gibson JL, Upshur RE. Pandemic influenza preparedness: an ethical framework to guide decision-making. BMC Med Ethics. 2006;7:E12.CrossRefPubMed
57.
go back to reference Dunn M, Sheehan M, Hope T, Parker M. Toward methodological innovation in empirical ethics research. Cambridge Q Healthcare Ethics. 2012;21:466.CrossRef Dunn M, Sheehan M, Hope T, Parker M. Toward methodological innovation in empirical ethics research. Cambridge Q Healthcare Ethics. 2012;21:466.CrossRef
58.
go back to reference THIS Institute. Testing times: an ethical framework and practical recommendations for COVID-19 testing for NHS workers. 2020. THIS Institute. Testing times: an ethical framework and practical recommendations for COVID-19 testing for NHS workers. 2020.
60.
go back to reference Lee LM. Public health ethics theory: review and path to convergence. J Law Med Ethics. 2012;40(1):85–98.CrossRefPubMed Lee LM. Public health ethics theory: review and path to convergence. J Law Med Ethics. 2012;40(1):85–98.CrossRefPubMed
63.
go back to reference Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Men Health. 2015;42(5):533–44.CrossRef Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Men Health. 2015;42(5):533–44.CrossRef
64.
go back to reference Fricker RD. Sampling methods for web and e-mail surveys. The SAGE handbook of online research methods. 2008. p. 195–216.CrossRef Fricker RD. Sampling methods for web and e-mail surveys. The SAGE handbook of online research methods. 2008. p. 195–216.CrossRef
65.
go back to reference Creswell JW, Plano Clark VL, Gutmann ML, Hanson WE. Advanced mixed methods research designs. In: Tashakkori A, Teddlie C, editors. Handbook of mixed methods in social and behavioral research. California: SAGE Publications; 2013. Creswell JW, Plano Clark VL, Gutmann ML, Hanson WE. Advanced mixed methods research designs. In: Tashakkori A, Teddlie C, editors. Handbook of mixed methods in social and behavioral research. California: SAGE Publications; 2013.
66.
67.
go back to reference Moseholm E, Fetters MD. Conceptual models to guide integration during analysis in convergent mixed methods studies. Methodological Innovations. 2017;10(2):205979911770311.CrossRef Moseholm E, Fetters MD. Conceptual models to guide integration during analysis in convergent mixed methods studies. Methodological Innovations. 2017;10(2):205979911770311.CrossRef
68.
go back to reference Heiberger RM, Robbins NB. Design of diverging stacked bar charts for Likert scales and other applications. J Stat Softw. 2014;57(5):1–32.CrossRef Heiberger RM, Robbins NB. Design of diverging stacked bar charts for Likert scales and other applications. J Stat Softw. 2014;57(5):1–32.CrossRef
70.
go back to reference Galel N, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.CrossRef Galel N, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.CrossRef
71.
go back to reference Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies. Qual Health Res. 2016;26(13):1753–60.CrossRefPubMed Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies. Qual Health Res. 2016;26(13):1753–60.CrossRefPubMed
73.
go back to reference Martindale AM, Pilbeam C, Mableson H, Tonkin-Crine S, Atkinson P, Borek A, Sheard S. Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England. BMC Public Health. 2021;21(1):1–8.CrossRef Martindale AM, Pilbeam C, Mableson H, Tonkin-Crine S, Atkinson P, Borek A, Sheard S. Perspectives on COVID-19 testing policies and practices: a qualitative study with scientific advisors and NHS health care workers in England. BMC Public Health. 2021;21(1):1–8.CrossRef
75.
go back to reference Raffle AE, Gray JM. Screening: evidence and practice: Oxford University Press, USA; 2019. Raffle AE, Gray JM. Screening: evidence and practice: Oxford University Press, USA; 2019.
76.
go back to reference Araz OM, Ramirez-Nafarrate A, Jehn M, Wilson FA. The importance of widespread testing for COVID-19 pandemic: systems thinking for drive-through testing sites. Health Systems. 2020;9(2):119–23.PubMedCentralCrossRefPubMed Araz OM, Ramirez-Nafarrate A, Jehn M, Wilson FA. The importance of widespread testing for COVID-19 pandemic: systems thinking for drive-through testing sites. Health Systems. 2020;9(2):119–23.PubMedCentralCrossRefPubMed
77.
go back to reference Kucharski AJ, Klepac P, Conlan AJ, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020;20(10):1151–60.PubMedCentralCrossRefPubMed Kucharski AJ, Klepac P, Conlan AJ, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020;20(10):1151–60.PubMedCentralCrossRefPubMed
78.
go back to reference MacIntyre CR. Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices. Lancet Infect Dis. 2020;20(10):1105–6.PubMedCentralCrossRefPubMed MacIntyre CR. Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices. Lancet Infect Dis. 2020;20(10):1105–6.PubMedCentralCrossRefPubMed
80.
go back to reference Pavelka M, Van-Zandvoort K, Abbott S, Sherratt K, Majdan M, Jarčuška P, et al. The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. Science. 2021;372(6542):635–41.PubMedCentralCrossRefPubMed Pavelka M, Van-Zandvoort K, Abbott S, Sherratt K, Majdan M, Jarčuška P, et al. The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. Science. 2021;372(6542):635–41.PubMedCentralCrossRefPubMed
81.
go back to reference Rajan S, McKee M, Hernández-Quevedo C, Karanikolos M, Richardson E, Webb E, Cylus, J. What have European countries done to prevent the spread of COVID-19? Lessons from the COVID-19 health system response monitor. Health Policy. 2022;126(5):355–61. Rajan S, McKee M, Hernández-Quevedo C, Karanikolos M, Richardson E, Webb E, Cylus, J. What have European countries done to prevent the spread of COVID-19? Lessons from the COVID-19 health system response monitor. Health Policy. 2022;126(5):355–61.
82.
go back to reference Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362–7.CrossRefPubMed Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362–7.CrossRefPubMed
83.
go back to reference Schuetz AN, Hemarajata P, Mehta N, Campbell S, Mitchell S, Palavecino E, et al. When should asymptomatic persons be tested for COVID-19? J Clin Microbiol. 2021;59(1):1–7. Schuetz AN, Hemarajata P, Mehta N, Campbell S, Mitchell S, Palavecino E, et al. When should asymptomatic persons be tested for COVID-19? J Clin Microbiol. 2021;59(1):1–7.
84.
go back to reference Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, et al. Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France. Eurosurveillance. 2021;26(1):2001978.PubMedCentralCrossRef Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, et al. Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France. Eurosurveillance. 2021;26(1):2001978.PubMedCentralCrossRef
85.
go back to reference Hernandez X, Valentinotti S. On an optimal testing strategy for workplace settings operating during the COVID-19 pandemic. PloS One. 2022;17(3):e0264060.PubMedCentralCrossRefPubMed Hernandez X, Valentinotti S. On an optimal testing strategy for workplace settings operating during the COVID-19 pandemic. PloS One. 2022;17(3):e0264060.PubMedCentralCrossRefPubMed
86.
go back to reference Wise J. Covid-19: concerns persist about purpose, ethics, and effect of rapid testing in Liverpool. BMJ. 2020;371:m4690.CrossRefPubMed Wise J. Covid-19: concerns persist about purpose, ethics, and effect of rapid testing in Liverpool. BMJ. 2020;371:m4690.CrossRefPubMed
87.
go back to reference Skittrall JP, Fortune MD, Jalal H, Zhang H, Enoch DA, Brown NM, et al. Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols. Lancet Reg Health Eur. 2021;1:100002.CrossRefPubMed Skittrall JP, Fortune MD, Jalal H, Zhang H, Enoch DA, Brown NM, et al. Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols. Lancet Reg Health Eur. 2021;1:100002.CrossRefPubMed
88.
go back to reference Sturdy S, Miller F, Hogarth S, Armstrong N, Chakraborty P, Cressman C, et al. Half a Century of Wilson & Jungner: reflections on the Governance of Population Screening. Wellcome Open Res. 2020;5:158.PubMedCentralCrossRefPubMed Sturdy S, Miller F, Hogarth S, Armstrong N, Chakraborty P, Cressman C, et al. Half a Century of Wilson & Jungner: reflections on the Governance of Population Screening. Wellcome Open Res. 2020;5:158.PubMedCentralCrossRefPubMed
89.
go back to reference Wilson JMG, Jungner G, Organization WH. Principles and practice of screening for disease. 1968. Wilson JMG, Jungner G, Organization WH. Principles and practice of screening for disease. 1968.
90.
go back to reference Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009;16(4):199–204.CrossRefPubMed Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009;16(4):199–204.CrossRefPubMed
91.
go back to reference Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949–65.PubMedCentralCrossRefPubMed Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949–65.PubMedCentralCrossRefPubMed
92.
go back to reference Krause J, Subklew-Sehume F, Kenyon C, Colebunders R. Acceptability of HIV self-testing: a systematic literature review. BMC Public Health. 2013;13(1):735.PubMedCentralCrossRefPubMed Krause J, Subklew-Sehume F, Kenyon C, Colebunders R. Acceptability of HIV self-testing: a systematic literature review. BMC Public Health. 2013;13(1):735.PubMedCentralCrossRefPubMed
93.
go back to reference Mahase E. Covid-19: Mass testing is inaccurate and gives false sense of security, minister admits. BMJ. 2020;371:m4916.CrossRef Mahase E. Covid-19: Mass testing is inaccurate and gives false sense of security, minister admits. BMJ. 2020;371:m4916.CrossRef
94.
go back to reference Wise J. Covid-19: Lateral flow tests miss over half of cases, Liverpool pilot data show. BMJ. 2020;371:m4848.CrossRefPubMed Wise J. Covid-19: Lateral flow tests miss over half of cases, Liverpool pilot data show. BMJ. 2020;371:m4848.CrossRefPubMed
95.
go back to reference Gray N, Calleja D, Wimbush A, Miralles-Dolz E, Gray A, De Angelis M, et al. Is “no test is better than a bad test”? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19. PLoS ONE. 2020;15(10):e0240775.PubMedCentralCrossRefPubMed Gray N, Calleja D, Wimbush A, Miralles-Dolz E, Gray A, De Angelis M, et al. Is “no test is better than a bad test”? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19. PLoS ONE. 2020;15(10):e0240775.PubMedCentralCrossRefPubMed
97.
go back to reference Sunjaya AF, Sunjaya AP. Pooled testing for expanding COVID-19 mass surveillance. Disaster Med Public Health Prep. 2020;14(3):e42–3.CrossRefPubMed Sunjaya AF, Sunjaya AP. Pooled testing for expanding COVID-19 mass surveillance. Disaster Med Public Health Prep. 2020;14(3):e42–3.CrossRefPubMed
98.
go back to reference Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8(8):Cd013705.PubMed Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8(8):Cd013705.PubMed
99.
go back to reference Tran NK, May L. Evolution of COVID-19 testing and the role of rapid antigen testing in a molecular-focused world. Arch Pathol Lab Med. 2022;146(4):404.CrossRefPubMed Tran NK, May L. Evolution of COVID-19 testing and the role of rapid antigen testing in a molecular-focused world. Arch Pathol Lab Med. 2022;146(4):404.CrossRefPubMed
100.
go back to reference Crozier A, Rajan S, Buchan I, McKee M. Put to the test: use of rapid testing technologies for covid-19. BMJ. 2021;372.CrossRefPubMed Crozier A, Rajan S, Buchan I, McKee M. Put to the test: use of rapid testing technologies for covid-19. BMJ. 2021;372.CrossRefPubMed
101.
go back to reference Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021;19(3):171–83. Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021;19(3):171–83.
102.
go back to reference Smith L, Potts HW, Amlot R, Fear N, Michie S, Rubin, J. Who is engaging with lateral flow testing for COVID-19 in the UK? The COVID-19 Rapid Survey of Adherence to Interventions and Responses (CORSAIR) study. BMJ Open. 2022;12:e058060. Smith L, Potts HW, Amlot R, Fear N, Michie S, Rubin, J. Who is engaging with lateral flow testing for COVID-19 in the UK? The COVID-19 Rapid Survey of Adherence to Interventions and Responses (CORSAIR) study. BMJ Open. 2022;12:e058060.
103.
go back to reference Martela F, Hankonen N, Ryan RM, Vansteenkiste M. Motivating voluntary compliance to behavioural restrictions: Self-determination theory–based checklist of principles for COVID-19 and other emergency communications. Eur Rev Soc Psychol. 2021;32(2):305–47. Martela F, Hankonen N, Ryan RM, Vansteenkiste M. Motivating voluntary compliance to behavioural restrictions: Self-determination theory–based checklist of principles for COVID-19 and other emergency communications. Eur Rev Soc Psychol. 2021;32(2):305–47.
105.
go back to reference Barbera J, Macintyre A, Gostin L, Inglesby T, O’Toole T, DeAtley C, et al. Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. JAMA. 2001;286(21):2711–7.CrossRefPubMed Barbera J, Macintyre A, Gostin L, Inglesby T, O’Toole T, DeAtley C, et al. Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. JAMA. 2001;286(21):2711–7.CrossRefPubMed
106.
go back to reference Giubilini A, Douglas T, Maslen H, Savulescu J. Quarantine, isolation and the duty of easy rescue in public health. Dev World Bioeth. 2018;18(2):182–9.CrossRefPubMed Giubilini A, Douglas T, Maslen H, Savulescu J. Quarantine, isolation and the duty of easy rescue in public health. Dev World Bioeth. 2018;18(2):182–9.CrossRefPubMed
107.
go back to reference Upshur R. The ethics of quarantine. AMA J Ethics. 2003;5(11):393–5. Upshur R. The ethics of quarantine. AMA J Ethics. 2003;5(11):393–5.
109.
go back to reference Patel J, Fernandes G, Sridhar D. How can we improve self-isolation and quarantine for covid-19? BMJ. 2021;372: n625.CrossRefPubMed Patel J, Fernandes G, Sridhar D. How can we improve self-isolation and quarantine for covid-19? BMJ. 2021;372: n625.CrossRefPubMed
110.
go back to reference Cevik M, Baral SD, Crozier A, Cassell JA. Support for self-isolation is critical in covid-19 response. BMJ. 2021;372:n224.CrossRefPubMed Cevik M, Baral SD, Crozier A, Cassell JA. Support for self-isolation is critical in covid-19 response. BMJ. 2021;372:n224.CrossRefPubMed
111.
go back to reference Stokel-Walker C. Covid-19: why test and trace will fail without support for self-isolation. BMJ. 2021;372:n327.CrossRefPubMed Stokel-Walker C. Covid-19: why test and trace will fail without support for self-isolation. BMJ. 2021;372:n327.CrossRefPubMed
112.
go back to reference Smith LE, Potts HWW, Amlôt R, Fear NT, Michie S, Rubin GJ. Adherence to the test, trace, and isolate system in the UK: results from 37 nationally representative surveys. BMJ. 2021;372:n608.PubMedCentralCrossRefPubMed Smith LE, Potts HWW, Amlôt R, Fear NT, Michie S, Rubin GJ. Adherence to the test, trace, and isolate system in the UK: results from 37 nationally representative surveys. BMJ. 2021;372:n608.PubMedCentralCrossRefPubMed
113.
go back to reference Limb M. Covid-19: Scientists and medics warn that it is too soon to lift all restrictions in England. BMJ Open. 2022;376:o469. Limb M. Covid-19: Scientists and medics warn that it is too soon to lift all restrictions in England. BMJ Open. 2022;376:o469.
114.
go back to reference Owens J, Cribb A. Beyond choice and individualism: understanding autonomy for public health ethics. Public Health Ethics. 2013;6(3):262–71.CrossRef Owens J, Cribb A. Beyond choice and individualism: understanding autonomy for public health ethics. Public Health Ethics. 2013;6(3):262–71.CrossRef
115.
go back to reference Zimmerman FJ. Public health autonomy: a critical reappraisal. Hastings Cent Rep. 2017;47(6):38–45.CrossRefPubMed Zimmerman FJ. Public health autonomy: a critical reappraisal. Hastings Cent Rep. 2017;47(6):38–45.CrossRefPubMed
116.
go back to reference Smith CB, Battin MP, Jacobson JA, Francis LP, Botkin JR, Asplund EP, et al. Are there characteristics of infectious diseases that raise special ethical issues? 1. Dev World Bioeth. 2004;4(1):1–16.CrossRefPubMed Smith CB, Battin MP, Jacobson JA, Francis LP, Botkin JR, Asplund EP, et al. Are there characteristics of infectious diseases that raise special ethical issues? 1. Dev World Bioeth. 2004;4(1):1–16.CrossRefPubMed
118.
go back to reference Van Buren HJ, Greenwood M. Enhancing employee voice: are voluntary employer-employee partnerships enough? J Bus Ethics. 2008;81(1):209–21.CrossRef Van Buren HJ, Greenwood M. Enhancing employee voice: are voluntary employer-employee partnerships enough? J Bus Ethics. 2008;81(1):209–21.CrossRef
119.
go back to reference Lee L. Public health ethics theory: review and path to convergence. J Law Med Ethics. 2012;40(1):85–98.CrossRefPubMed Lee L. Public health ethics theory: review and path to convergence. J Law Med Ethics. 2012;40(1):85–98.CrossRefPubMed
120.
go back to reference Screening STaFGoM. Multidisciplinary task and finish group on mass testing: consensus statement for SAGE. 2020. Screening STaFGoM. Multidisciplinary task and finish group on mass testing: consensus statement for SAGE. 2020.
121.
go back to reference Manno M, Sito F, Licciardi L. Ethics in biomonitoring for occupational health. Toxicol Lett. 2014;231(2):111–21.CrossRefPubMed Manno M, Sito F, Licciardi L. Ethics in biomonitoring for occupational health. Toxicol Lett. 2014;231(2):111–21.CrossRefPubMed
122.
go back to reference Blendon RJ, DesRoches CM, Cetron MS, Benson JM, Meinhardt T, Pollard W. Attitudes toward the use of quarantine in a public health emergency in four countries. Health Aff (Millwood). 2006;25(2):w15-25.CrossRef Blendon RJ, DesRoches CM, Cetron MS, Benson JM, Meinhardt T, Pollard W. Attitudes toward the use of quarantine in a public health emergency in four countries. Health Aff (Millwood). 2006;25(2):w15-25.CrossRef
123.
go back to reference Van Hooste WLC, Bekaert M. To be or not to be vaccinated? The ethical aspects of influenza vaccination among healthcare workers. Int J Environ Res Public Health. 2019;16(20):3981.PubMedCentralCrossRef Van Hooste WLC, Bekaert M. To be or not to be vaccinated? The ethical aspects of influenza vaccination among healthcare workers. Int J Environ Res Public Health. 2019;16(20):3981.PubMedCentralCrossRef
124.
go back to reference Have Mt, van der Heide A, Mackenbach JP, de Beaufort ID. An ethical framework for the prevention of overweight and obesity: a tool for thinking through a programme’s ethical aspects. Eur J Public Health. 2012;23(2):299–305.CrossRefPubMed Have Mt, van der Heide A, Mackenbach JP, de Beaufort ID. An ethical framework for the prevention of overweight and obesity: a tool for thinking through a programme’s ethical aspects. Eur J Public Health. 2012;23(2):299–305.CrossRefPubMed
125.
go back to reference Hunt MK, Lederman R, Stoddard AM, LaMontagne AD, McLellan D, Combe C, et al. Process evaluation of an integrated health promotion/occupational health model in wellworks-2. Health Educ Behav. 2005;32(1):10–26.CrossRefPubMed Hunt MK, Lederman R, Stoddard AM, LaMontagne AD, McLellan D, Combe C, et al. Process evaluation of an integrated health promotion/occupational health model in wellworks-2. Health Educ Behav. 2005;32(1):10–26.CrossRefPubMed
126.
go back to reference Carolan S, Harris PR, Cavanagh K. Improving employee well-being and effectiveness: systematic review and meta-analysis of web-based psychological interventions delivered in the workplace. J Med Internet Res. 2017;19(7):e271.PubMedCentralCrossRefPubMed Carolan S, Harris PR, Cavanagh K. Improving employee well-being and effectiveness: systematic review and meta-analysis of web-based psychological interventions delivered in the workplace. J Med Internet Res. 2017;19(7):e271.PubMedCentralCrossRefPubMed
127.
go back to reference Proper KI, Van Oostrom SH. The effectiveness of workplace health promotion interventions on physical and mental health outcomes – a systematic review of reviews. Scand J Work Environ Health. 2019;45(6):546–59.CrossRefPubMed Proper KI, Van Oostrom SH. The effectiveness of workplace health promotion interventions on physical and mental health outcomes – a systematic review of reviews. Scand J Work Environ Health. 2019;45(6):546–59.CrossRefPubMed
128.
go back to reference Quirk H, Crank H, Carter A, Leahy H, Copeland RJ. Barriers and facilitators to implementing workplace health and wellbeing services in the NHS from the perspective of senior leaders and wellbeing practitioners: a qualitative study. BMC Public Health. 2018;18(1):1362.PubMedCentralCrossRefPubMed Quirk H, Crank H, Carter A, Leahy H, Copeland RJ. Barriers and facilitators to implementing workplace health and wellbeing services in the NHS from the perspective of senior leaders and wellbeing practitioners: a qualitative study. BMC Public Health. 2018;18(1):1362.PubMedCentralCrossRefPubMed
129.
go back to reference Rongen A, Robroek SJW, van Ginkel W, Lindeboom D, Pet M, Burdorf A. How needs and preferences of employees influence participation in health promotion programs: a six-month follow-up study. BMC Public Health. 2014;14(1):1277.PubMedCentralCrossRefPubMed Rongen A, Robroek SJW, van Ginkel W, Lindeboom D, Pet M, Burdorf A. How needs and preferences of employees influence participation in health promotion programs: a six-month follow-up study. BMC Public Health. 2014;14(1):1277.PubMedCentralCrossRefPubMed
Metadata
Title
Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework
Authors
Jan W. van der Scheer
Akbar Ansari
Meredith McLaughlin
Caitríona Cox
Kathleen Liddell
Jenni Burt
Jenny George
Rebecca Kenny
Ruth Cousens
Brandi Leach
James McGowan
Katherine Morley
Janet Willars
Mary Dixon-Woods
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-13993-1

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue